drug · unknown
Maci
Phase 3updated 5mo agoby $VCEL Vericel Corp🔗 ChEMBL
Phase 3community read0 votes
Unknown drug with a maximum clinical stage of Approval (across all indications), with an approval for articular cartilage disorder and cartilage disease and 1 investigational indication.
all catalysts(0)
nothing on the calendar yet
Trials studying Maci
- phase2Study of AVZO-021 in Patients With Advanced Solid Tumors
- phase1A Study of Abemaciclib (LY2835219) in Healthy Participants
- phase3A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- phase2Imlunestrant/Abemaciclib/Selinexor in Ovarian and Endometrial
- phase2ALPINE: Maintenance Letrozole/Abemaciclib
- phase3BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
- phase2Fulvestrant Plus Abemaciclib in Women With Advanced Low Grade Serous Carcinoma
- phase3A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 7m ago
Found something off?
comments(0)
5-min edit window · permanent after that